ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

July 9-13, 2022. London, England, UK.

View by Title View by Number View Themes
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB0256

    D Dimer levels in Children with Kawasaki Disease correlate with disease activity

    S. Rajasekaran1, A. Jindal2, N. Kumar3, V. Uppal4, S. Singh5, J. Ahluwalia5

  • Abstract Number: PO0008

    D-dimer in SARS-CoV-2 ! its importance in diagnosis and treatment.

    E. LOURENCO1, A. JAKHI2, N. THOMAS2, A. PANDEY2, D. SHEIKH2, D. KRIPLANI2, D. ANTIA2

  • Abstract Number: PB0905

    D-dimer level measured at first incident cancer-related venous thromboembolism is a predictor for recurrence: a retrospective cohort study

    H. Almajed1, F. Aleidan2

  • Abstract Number: VPB0120

    D-Dimer Levels at Admission for Predicting In-Hospital Mortality in COVID-19 Patients

    V. Irawan1, L. Rotty2, P. Lasut2, C. Hendratta2, H. Haroen2

  • Abstract Number: PB1002

    Daratumumab as an Adjunctive Therapy for Acquired Hemophilia A with Poor Prognostic Markers

    C. Moonla1, C. Polprasert1, S. Krittikarux2, S. Krajibthong3, T. Chajuwan4, A. Sukperm1, B. Akkawat1, P. Rojnuckarin1, N. Uaprasert1

  • Abstract Number: PB0821

    Data mining for profiling the mutational landscape of von Willebrand disease

    O. Seidizadeh1, A. Cairo2, L. Baronciani3, M.T. Pagliari4, S. Siboni5, E. Biguzzi6, F. Peyvandi7

  • Abstract Number: PB0273

    Dealing with pediatric cancer associated thrombosis: a monocentric retrospective cohort study

    E. Campello1, A. Francavilla1, S. Sartori1, C. Forestan1, S. Sebellin1, m. Pelizza2, M. Nosadini1, J. Pin1, A. Biffi1, D. Gregori1, G. Lorenzoni1, M. Martinato1, P. Simioni3

  • Abstract Number: PB0532

    Deciphering the role of small sulfated molecule PTS on AT3 structure and in vitro clot formation.

    I. Ahmad1, M. Abid2, S. Deep3, M. Jairajpuri4

  • Abstract Number: PB0375

    Deciphering the TLT-1 Fibrinogen ligand interaction.

    s. Branfield1, X. Vales2, A. Washington3, C. wu4, P. Akamine2, J. González2

  • Abstract Number: PB1362

    Decision-analysis modelling of effectiveness and cost-effectiveness of thromboprophylaxis for medical inpatients

    D. Horner1, S. Davis2, S. Goodacre2, A. Pandor2, M. Holland3, K. de Wit4, B. Hunt5, X. Griffin6

  • Abstract Number: PB0486

    Decompensated cirrhosis with bacterial infections shows a peculiar derangement of the hemostatic balance

    E. Campello1, A. Zanetto2, C. Bulato2, S. Gavasso2, G. Saggiorato2, N. Perin2, S. Shalaby2, P. Burra2, M. Senzolo3, P. Simioni4

  • Abstract Number: OC 57.4

    Decreased DNase activity in severe COVID-19 correlates with increased circulating NET burden

    C. Martens1, S. Kraisin2, L. Velásquez Pereira3, R. Lavend'homme4, C. Jacobs5, L. Vanderbeke6, E. Wauters7, P. Verhamme3, T. Witsch8, M. Jacquemin9, J. Wauters10, K. Martinod1

  • Abstract Number: PB0026

    Decreased Levels of Factor VIII During Acute Ischemic Stroke Predict Excellent Outcome Thirty Days After

    M. El Horri1, F. Bemmoussat1, R. Messaoudi2, M. Moueden2, F. El Horri3, D. Benlaldj4, I. Khachaa1, G. Khitri5, A. Chikh Khelifa6, M. Smahi1, K. Benbouhadi1, K. Kebir1, S. Zatir1, L. Benmahdi1, H. BROUK7

  • Abstract Number: PB1310

    Decreased mitochondrial DNA copy number in patients with history of recurrent venous thromboembolism

    R. Vostatek1, C. Englisch2, P. Hohensinner3, S. Nopp4, I. Pabinger5, C. Ay5

  • Abstract Number: OC 63.1

    Decreased thrombin generation profile is associated with severe bleeding phenotype in hemophilia: data from the Hemophilia in the Netherlands study

    M. Verhagen1, W. van Heerde2, J. van der Bom3, E. Beckers4, N. Blijlevens5, M. Coppens6, S. Gouw7, J. Jansen8, F. Leebeek9, L. van Vulpen10, D. Meijer8, S. Schols11

  • Abstract Number: OC 69.2

    Deep learning of structural variations: genomic and bioinformatic lessons from antithrombin deficiency.

    B. de la Morena-Barrio1, J. Cuencia-Guardiola2, C. Orlando3, A. Sanchis-juan4, J. García5, J. Padilla6, M. de la Morena-Barrio7, M. Puruunen8, K. Stouffs3, R. Cifuentes-Riquelme7, C. Bravo-Pérez9, R. Benito10, V. Vicente7, F. vidal11, J. Hernández-Rivas12, W. Ouwehand13, J. fernández-breis2, K. Jochmans3, M. Lozano7, J. Corral7

  • Abstract Number: OC 53.2

    Deep mutational scan of the VWF C domains to define mutations associated with VWD

    T. Sparring1, H. Madarati2, K. Singh3, C. Kretz2

  • Abstract Number: OC 42.2

    Deep Vein Thrombosis and Pulmonary Embolism Rates in Total Hip and Total Knee Arthroplasty Patients-A Claims Database Study

    S. Simon1, R. Patell2, B. Hollenbeck1

  • Abstract Number: PO0066

    Deep vein thrombosis of the forearm after fracture immobilization

    D. Stambolieva1, V. Gjorgjevska2, S. Ortakovska3

  • Abstract Number: VPB0283

    Deep venous thrombosis in a child with Down syndrome as a presenting manifestation of acute lymphoblastic leukemia

    A. Jovanovska1, K. Martinova2, S. Kocheva2, Z. Trajkova-Antevska2, K. Kuzevska-Maneva2, B. Gjurkova-Angelovska2

  • Abstract Number: VPB0364

    Defective megakaryopoiesis in ETV6-variant carriers results from an aberrant megakaryocyte-erythroid progenitor population

    T. Bigot1, E. Gabinaud1, L. Hannouche1, V. Sbarra1, D. Payet-Bornet2, M. Loosveld3, D. Potier2, M. Alessi1, M. Poggi1

  • Abstract Number: PB1261

    Delayed CCL26 trafficking in the secretory pathway of STX5 depleted Endothelial Cells

    S. Hordijk1, M. Kat2, R. Bierings3

  • Abstract Number: PB0006

    Delayed Diagnosis of Acquired Hemophilia A Results in Worse Clinical Outcome

    S. Stankovikj1, n. Ridova2, s. Stojanovska2, t. Ristevska2, M. Cvetanoski2

  • Abstract Number: VPB0902

    Deletion of TGF-β1 on platelets attenuates pulmonary arterial hypertension by enhancing aerobic glycolysis of pulmonary arterial smooth muscle cell

    Z. Ming, Y. Zhu, X. Gong, M. Lu, X. Zeng, J. Gao, Y. Guo, L. Liu, R. Ma

  • Abstract Number: PB0664

    Demographic and Baseline Clinical Characteristics of Patients With Hemophilia A in China: Real-world Data From the AHEAD International Study

    R. Wu1, Z. Li2, J. Sun3, X. Du4, X. Zhang5, Y. Wang6, Q. Hu7, R. Zhou8, J. Gu9, R. Guerra9, L. Tang10, R. Yang11

  • Abstract Number: PB0598

    Demonstration of Prothrombotic Status in patients with COVID-19 using Thromboelastography and a Novel T-TAS assay

    P. kundan1, K. Bliden1, U. Tantry2, s. Duhan3, s. arvind1, A. Singh1, P. Gurbel4

  • Abstract Number: VPB1389

    Descriptive analysis of venous thromboembolic disease in patients under contraceptive treatment in sector III of Aragón

    I. Rivas Estabén1, A. Ortiz López2, S. Angós Vázquez3, N. Gemperle Ortiz3, M. Moles Guerrero3, V. Murillo Cortés3, O. Gavín Sebastian3, L. Palomera Bernal3

  • Abstract Number: PB1156

    Desmopressin in hemophilia A carriers: determinants and duration of FVIII response

    L. Romano1, T. den Hertog2, G. Mulders-van der Meer2, M. Cnossen3, F. Leebeek4, M. Kruip5

  • Abstract Number: PB0868

    Detection of hyperfunctioning platelets and novel phenotypic platelet subtypes

    M. Jongen, L. Schmied, S. Meinke, R. Fiskesund, P. Höglund

  • Abstract Number: PB0177

    Detection of IgG4 anti-FVIII levels as complementary test to define the ITI outcome in patients with hemophilia A: results from the BrazIT Study

    D. Chaves1, B. Ayala2, R. Camelo3, L. Etto4, A. De Oliveira5, V. Franco6, M. Roberti7, R. Ribeiro8, M. De Cerqueira9, F. Callado10, T. Anegawa11, M. Cerqueira12, S. Rezende2

  • Abstract Number: OC 33.4

    Detection of platelet-activating antibodies associated with VITT by flow cytometry: an italian experience

    S. Sorrentino1, F. Cesari2, A. Gori2, R. De Cristofaro3, B. Giusti4, A. Rogolino2, E. Sticchi2, E. De Candia3, R. Marcucci2

  • Abstract Number: PB1146

    Determinants of successful immune tolerance induction in persons with hemophilia A – systematic review and meta-analysis

    I. Oomen1, R. Camelo2, S. Rezende3, J. Voorberg4, M. Mancuso5, J. Oldenburg6, M. Carcao7, D. Matino8, D. Lillicrap9, K. Fischer10, K. Fijnvandraat1, S. Gouw11

  • Abstract Number: PB0622

    Determining the dominant-negative causality of FXIII heterozygous mutations using a bi-cistronic, bi-tagged expression system

    H. Javed1, S. Singh2, S. Ramaraje Urs3, J. Oldenburg4, A. Biswas3

  • Abstract Number: OC 54.4

    Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty

    B. Nemeth1, M. Smeets2, A. Pedersen3, E. Kristiansen3, M. Whyte4, L. Roberts5, S. de Lusignan6, S. le Cessie7, S. Cannegieter2, R. Arya8

  • Abstract Number: VPB0472

    Development of a consensus-based cross-domain protocol for the management of elastic compression stocking therapy: a modified Delphi study

    R. Schreurs, M. Joore, H. ten Cate, A. ten Cate

  • Abstract Number: PB0147

    Development of a microfluidic model to evaluate extracorporeal circuit material thrombogenicity

    L. Gao1, J. Hong2, B. Akhavan3, A. Waterhouse4

  • Abstract Number: PB0729

    Development of a viral vector for hemopexin protein expression for gene therapy in disorders associated with increased levels of free extracellular heme

    F. Lima1, B. Hounkpe1, C. Peachazepi de Moraes2, I. Borba3, F. Costa1, E. de Paula4

  • Abstract Number: PB0867

    Development of an endothelialized in vitro thrombosis model with a disease relevant extracellular matrix

    A. Drysdale1, A. Unsworth2, S. White1, S. Jones1

  • Abstract Number: VPB0233

    Development of clinical pharmacist led Anticoagulation stewardship program in cardiac care setting in developing country.

    S. khan1, M. qureshi2, A. jahangir2

  • Abstract Number: PB1244

    Development of Consensus on Standardized Nomenclature for PT-VWD- Joint Project from the ISTH SSCs on Platelet Physiology, VWF and Genomics in thrombosis and Haemostasis

    M. Othman1, M. Lavin2, R. Li3, A. Elsebaie1, P. Gresele4

  • Abstract Number: PB0805

    Development of Personalized CRISPR/Cas9 Based Gene Correction Therapy for Von Willebrand Disease

    I. Bär1, P. Burgisser2, R. Bierings3, J. Eikenboom4, C. van Kwawegen1, F. Leebeek2, J. Voorberg5

  • Abstract Number: OC 29.4

    Development of recombinant antibodies targeting the coagulation factor XIII-B subunit for research and therapeutic use

    J. Byrnes, C. Bracken, J. Wells

  • Abstract Number: PB0235

    Diagnosis, predisposing factors, and Management of Disseminated Intravascular Coagulation in neonatal Intensive care Unit in a tertiary Care Hospital

    R. Akbar

  • Abstract Number: OC 31.4

    Diagnostic accuracy of V/Q and Q SPECT/CT in patients with suspected pulmonary embolism: a systematic review and meta-analysis

    A. Venturini1, A. Squizzato2, V. Pelitti1, B. Bellini1, M. Bernasconi3, A. Corso4, N. Riva5, T. Depalo4

  • Abstract Number: PB0974

    Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism

    D. Luijten1, F. Meijer2, G. Boon3, Y. Ende-Verhaar3, R. Bavalia4, L. El Bouazzaoui5, M. Delcroix6, A. Mairuhu7, M. Huisman8, S. Middeldorp9, P. Pruszcyk10, D. Ruigrok11, P. Verhamme12, A. Vonk Noordegraafonk Noordegraaf11, J. Vriend13, H. Vliegen2, F. Klok14

  • Abstract Number: VPB0839

    Diagnostic Errors Of Von Willebrand Disease In A Developing Country: Analysis Of 38 Years Data

    L. Hambardzumyan, N. Martirosyan1, A. Movsisyan2, M. Badikyan3, N. Sargsyan4, G. Tamamyan5, A. Ter-Grigoryan6

  • Abstract Number: PB1093

    Diagnostic Potential of Rapid Automated ADAMTS13 Inhibitor Screening and Quantification

    G. Moore1, M. Griffiths2, N. Binder2

  • Abstract Number: VPB0138

    Diagnostic strategies for pulmonary embolism in patients hospitalized for COVID-19: role of clinical prediction rules

    M. Vedovati, F. Balducci, C. Becattini

  • Abstract Number: VPB1117

    Diagnostic Value Of Tromboelastography Using Korean Society On Thrombosis And Haemostasis Criteria On Disseminated Intravascular Coagulation Induced Sepsis Patients

    S. Fatonah1, A. Fatoni2, H. Wiraharjanegara3, R. Adawiyah3

  • Abstract Number: VPB1020

    Dielectric blood coagulometry for evaluation of coagulation activity of blood samples spiked with direct oral anticoagulant.

    A. Takemoto1, N. Kondo2, H. Yamamoto2, Y. Yamamoto3, S. Toyama4, K. Higashino5, T. Uchida4

  • Abstract Number: OC 50.4

    Differences in bleeding profiles and venous clot structures between emicizumab and factor VIII-treated mice

    T. SEFIANE1, V. Muczynski2, X. Heiligenstein3, O. Christophe2, C. Denis2, C. Casari4, P. Lenting2

  • Abstract Number: PB1316

    Differences in coagulation parameters associated with glucocorticoid treatment in patients with a first venous thrombosis: data from the MEGA study

    E. Camilleri1, N. van Rein1, N. Biermasz2, O. Dekkers3, R. Feelders4, M. Huisman5, M. Kaya6, F. Klok7, O. Meijer8, A. Pereira8, F. Rosendaal9, F. Shokri10, B. van Vlijmen11, S. Cannegieter1

  • Abstract Number: OC 38.3

    Different contribution of monocyte- and platelet-derived microvesicles to endothelial behavior

    M. Brambilla1, M. Talmon2, P. Canzano1, L. Fresu2, M. Conti3, A. Becchetti1, E. Tremoli4, M. Camera5

  • Abstract Number: VPB0365

    Differential Autoregulation of RUNX1 by Isoforms RUNX1 B and RUNX1 C in Megakaryocytic Cells

    L. Guan1, A. Rao2

  • Abstract Number: PB0601

    Differential expression of platelet microRNAs in hospitalized patients with severe COVID-19

    M. Pócsi1, Z. Fejes2, H. Ghansah1, R. Sütő3, Z. Szabó3, S. Póliska4, Á. Gyetvai4, Z. Szentkereszty3, J. Kappelmayer4, B. Nagy4

  • Abstract Number: OC 09.3

    Differential fate of Von Willebrand factor and Von Willebrand factor propeptide following release from platelet alpha-granules

    M. Swinkels1, T. Lemmens2, P. Burgisser3, J. Slotman4, A. Houtsmuller4, J. Cosemans2, F. Leebeek3, J. Voorberg5, A. Jansen6, R. Bierings7

  • Abstract Number: PB0550

    Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa

    J. Lewis1, O. Iqbal2, W. Jeske2, D. Hoppensteadt3, F. Siddiqui2, B. Lewis2, J. Fareed3

  • Abstract Number: PB1308

    Differential proteomic profile of patients with Pulmonary Embolism (PE) related to events during follow-up: chronic thromboembolic pulmonary hypertension (CTEPH) or occult cancer.

    V. Sánchez López1, E. Mendoza Zambrano2, J. Oto3, E. Arellano Orden1, O. Tura Ceide4, C. FONT5, M. Saez6, P. Medina7, I. Blanco8, J. Barberà9, R. Otero Candelera1

  • Abstract Number: PB0508

    Differential quantitative proteomics reveals potential molecular mechanisms responsible for platelet hyperactivity and increased thrombotic risk in diabetes mellitus patients.

    R. Haghiri Limoudehi1, N. Wolska2, M. Moritz3, H. Voss3, H. Schlüter4, G. Pula5

  • Abstract Number: PB0406

    Differential regulation of GPVI-stimulated Y/S phosphorylation of Syk and Btk by both PKC and PKA in human platelets

    P. Zhang1, F. Solari2, U. Walter3, J. Heemskerk4, A. Sickmann5, K. Jurk6

  • Abstract Number: PB1068

    Dilute Thrombin Time versus activated Partial thromboplastin Time to monitor Argatroban in critically ill patients.

    S. Cox-Morton, D. White, E. Duff, M. Sharp, C. Bridgeman, M. Kirk, C. Moore, M. Besser, M. Robinson, E. Symington, W. Thomas, S. MacDonald

  • Abstract Number: PB0748

    Diminished platelet CLEC-2 sensitivity in kaposiform hemangioendothelioma identified with novel CLEC-2 antagonists

    A. Martyanov1, I. Tesakov2, O. An1, A. Ignatova2, G. Svidelskaya3, L. Khachatryan3, J. Eble4, D. Kalinin5, A. Sveshnikova3

  • Abstract Number: PB0984

    Direct comparison of Andexanet alfa and prothrombin complex concentrates in the reversal of direct factor Xa inhibitors – An in vitro study

    H. Brinkman1, M. Zuurveld2, J. Meijers3

  • Abstract Number: OC 17.5

    Direct Oral Anti-Coagulant (DOAC) external quality assessment (EQA) scheme assay results and interpretations from UKNEQAS BC DOAC Survey 19 2021.

    C. Reilly-Stitt1, A. Lowe1, I. Jennings2, S. Kitchen3, D. Kitchen4, I. Walker1

  • Abstract Number: OC 62.5

    Direct oral anticoagulant prescribing in patients with a very low bodyweight – experience from King’s College Hospital

    R. Clapham1, V. Speed2, R. Byrne1, R. Patel2, R. Arya2, J. Patel2

  • Abstract Number: OC 51.1

    Direct oral anticoagulants cause placental vascular abnormalities and epigenetic reprogramming in placenta and the offspring

    K. Singh1, A. Gupta1, R. Younis1, H. Mai1, K. Shahzad2, B. Isermann2, S. Kohli2

  • Abstract Number: PB0443

    Direct Oral Anticoagulants compared with Warfarin for the Treatment of Left Ventricular Thrombosis post Myocardial Infarction

    R. Byrne1, J. Czuprynska1, V. Speed1, J. Byrne1, P. Scott1, R. Clapham1, R. Patel2, L. Roberts1, R. Arya2, J. Patel3

  • Abstract Number: OC 48.3

    Direct Oral Anticoagulants for the Treatment of Splanchnic Vein Thrombosis: A Systematic Review and Meta-Analysis

    A. Li1, P. Li2, M. Zhang3, A. Eshaghpour4, M. Carrier5, M. Crowther6

  • Abstract Number: PB0928

    Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Patients with Hematological Malignancies

    R. Robinson1, G. Spectre2, M. Lishner3, O. Sharabi4, E. Robinson5, O. Hamburger Avnery6, A. Gafter-Gvili7, P. Raanani2, A. Leader8

  • Abstract Number: PB0449

    Direct oral anticoagulants in the management of cerebral sinus vein thrombosis: A single centre experience

    U. Faruqi1, V. Grilo2, P. Holmes3, S. Wong3, K. Breen4

  • Abstract Number: PB1255

    Disclosing the role of endothelial dysfunction in the pathogenesis of unprovoked venous thromboembolism by using patient-specific endothelial colony-forming cells

    A. Cancellara1, M. Bacci2, L. Bertolani3, E. Romualdi4, V. Pessi5, C. Lodigiani2, M. Donadini6, S. Della Bella1, F. Calcaterra1, D. Mavilio1

  • Abstract Number: PB1208

    Discontinuation of thrombopoietin receptor agonists: a 10 year real-world experience from an academic hospital in Madrid

    A. Ramírez López1, M. Alvarez-Román2, M. Martín Salces1, M. Rivas Pollmar3, E. Monzón Manzano1, E. Arias Salgado1, P. Acuña1, V. Jiménez Yuste4, N. Butta1

  • Abstract Number: PB1075

    Discrepant results for ADAMTS13 assays with different activity assays. Artefact or cause for concern?

    I. Jennings1, C. Reilly-Stitt1, D. Kitchen2, A. Lowe1, S. Kitchen3, I. Walker1

  • Abstract Number: PB0877

    Discriminating platelet subpopulations on the expression level of HLA-I highlights the high reactivity of young versus old platelets

    C. Angénieux1, A. Couvidou1, N. Brouard1, A. Eckly2, P. Mangin1, B. Maître1

  • Abstract Number: PB1066

    Discrimination between acquired hemophilia A and lupus anticoagulant using global coagulation assays

    Y. Chikasawa1, K. Amano2, K. Shinozawa3, Y. Harada3, A. Mitsuhashi4, R. Miyashita3, T. Yamaguchi3, Y. Kamikubo3, A. Ichiki3, M. Bingo5, R. Sekiya3, T. Muramatsu3, M. Yotsumoto6, T. Hagiwara6, I. Hiroshi3, E. Kinai6

  • Abstract Number: OC 04.4

    Disease Relapse in immune Thrombotic Thrombocytopenic Purpura and treatment with Anti-CD20 Monoclonal Antibodies – 10-years’ experience from the UK TTP Registry

    A. Doyle1, M. Stubbs2, T. Dutt3, W. Lester4, W. Thomas5, J. Vanveen6, J. Hermans7, T. Cranfield8, Q. Hill9, B. Hunt1, A. Clark10, T. Nokes11, S. Benjamin12, C. Bagot13, N. Cooper14, S. Austin15, M. Thomas2, J. Westwood2, M. Scully2

  • Abstract Number: VPB0518

    Disentangle the relationship between depression and arterial thrombosis associated with BDNFVal66Met polymorphism: the role of α 2-adrenergic receptor pathway

    L. Sandrini1, P. Amadio1, A. Ieraci2, M. Alessandro3, J. Werba4, P. Soprano3, A. Balduini5, M. Zarà1, A. Bonomi6, F. Veglia6, G. Colombo7, M. Popoli8, F. Lee9, E. Tremoli10, S. Barbieri1

  • Abstract Number: PB0775

    Disruption of the interaction of platelets with leukocytes by a novel short synthetic peptide targeting P-selectin

    S. Wallis1, N. Wolska2, M. Posner3, A. Upadhyay4, T. Renné5, I. Eggleston6, S. Bagby1, G. Pula7

  • Abstract Number: PO0046

    Distribution of Inherited Thrombophilia Disorder and Experiences of Extremely Low Level of Protein-C: A Single-Center Study

    W. AHN1, S. Hahn2, J. Han3, C. Lyu3

  • Abstract Number: PB0191

    DNA extracellular traps as potential biomarker of chronic haemophilic synovitis and therapeutic perspective in patients treated with PRP

    P. Oneto1, M. Landro2, C. Daffunchio2, A. Douglas Price3, E. Carrera SIlva1, H. Caviglia2, J. Etulain4

  • Abstract Number: VPB0647

    DNase 1 unveils the presence and unlocks the thrombolytic potential of intraveneously administered t-PA in large vessel occlusion acute ischemic stroke

    L. Di Meglio1, M. Solo Nomenjanahary2, M. BOURRIENNE3, V. Ollivier2, M. Mazighi4, B. Ho-Tin-Noé5, J. Desilles6

  • Abstract Number: PB1197

    Do Regulatory T cells Reemerge with Resolution of Childhood Immune Thrombocytopenia?

    P. Bangalore Parthasarathy1, M. Mundell2, B. Race2, P. Rayman2, M. Diaz2, S. Swaidani2, R. Talati3, K. McCrae4

  • Abstract Number: PO0060

    DOACs CHALLENGING CHOICE IN CONCOMITANT JUGULAR VEIN AND HEPATIC ARTERY THROMBOSIS IN A BREAST CANCER PATIENT WITH LIVER ARTERIAL INFUSION CHEMOTHERAPY (LAIC): A UNIQUE CLINICAL CASE.

    A. Fioretti1, T. Leopizzi2, M. Porcelli3, V. Fazio4, G. Ranieri4, G. Luzzi5, C. Gadaleta3, S. Oliva6

  • Abstract Number: OC 43.5

    Domain-specific nanobodies distinguish intact and proteolyzed forms of von Willebrand factor in congenital von Willebrand disease

    C. Kizlik-Masson1, I. Peyron2, S. Gangnard3, M. Clavel3, V. Regnault4, E. Jeanpierre5, A. Dupont6, O. Christophe3, C. Casari7, C. Denis3, S. Susen8, P. Lenting3

  • Abstract Number: VPB0690

    Dose optimisation in children with severe haemophilia A on long-term octanate® prophylaxis

    E. Dmitriev

  • Abstract Number: PB0193

    Dose optimization for prophylaxis using a pharmacokinetic model for factor IX products in severe hemophilia B

    B. Vandewalle1, G. Castaman2, M. Alvarez-Román3, C. Escuriola Ettingshausen4, L. Nemes5, R. Tomic6, P. Martins1, J. Rodrigues7, K. Pinachyan8

  • Abstract Number: PB1184

    Dose-effect analyses of FEIBA in low volume plasma samples of inhibitor patients using a newly defined chemiluminescent-based TGA

    D. Steeghs1, C. van de Ridder2, M. van Geffen1, C. van 't Veer1, W. van Heerde1

  • Abstract Number: OC 57.5

    Downregulation of Thrombomodulin-Thrombin-Activated Protein C pathway as a mechanism for SARS-CoV-2 induced endotheliopathy and microvascular thrombosis

    S. Agarwal1, P. Jacobi2, S. Sartain2

  • Abstract Number: PB0410

    DRVVT in APLA- As a single test and in combination with Anti B2-Glycoprotein and Anti Cardiolipin.

    P. Balasubramanian1, T. Geevar2, R. Dave2, J. Jude prakash3, J. Mathew3, A. Abraham4, J. L3, S. Nair2

  • Abstract Number: PB0786

    Dual anti-platelet therapy-associated bleeding is exacerbated by platelet counts < 100 x 10^9/L in mice due to impaired initial hemostatic plug formation

    R. Lee, A. Ballard, T. Rudran, T. Kawano, N. Mackman, G. Stouffer, W. Bergmeier

  • Abstract Number: PB0509

    Dual Antiplatelet Therapy Is Associated With High α-Tubulin Acetylation in Platelets From Coronary Artery Disease Patients

    V. Robaux1, S. Kautbally2, A. Ginion1, M. Dechamp3, S. Lejeune2, L. Bertrand1, S. Horman4, C. Beauloye5

  • Abstract Number: OC 11.4

    Dynamic changes in activated protein C during major haemorrhage protocol and associated fibrinolytic response

    A. Thaventhiran1, K. Brohi2, R. Davenport3

  • Abstract Number: VPB0127

    DYNAMICS OF HEMOSTASIS SYSTEM’S PARAMETERS IN PATIENTS WITH SEVERE COURSE OF COVID-19 UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION

    E. Klychnikova, I. Ivanov, E. Tazina, S. Zhuravel, K. Popugaev, S. Petrikov

  • Abstract Number: PB0482

    Dysfunctional Hemostasis in Patients under Extracorporeal Life Support. A Rapid Diagnostic Approach with Therapeutical Guidance Intentions

    A. Moreno-Castaño1, E. Sandoval2, M. Pino2, S. Samanbar3, L. Bonastre2, P. Molina2, S. Fernández2, H. Ventosa4, G. Escolar4, P. Castro2, M. Diaz-Ricart5

  • Abstract Number: OC 29.5

    Dysregulated fibrinogen γ-chain cross-linking in FibγΔ5 mice drives acute liver injury after acetaminophen overdose

    L. Poole1, D. Groeneveld1, H. Cline-Fedewa1, M. Flick2, J. Luyendyk3

Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley